Novocure Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +113.6% | +150.5% | +113.6% | +40.1% | +41.6% | +40.7% | +8.2% | +0.5% | -5.3% | +18.8% | +8.3% | |
| – | +105.4% | +124.6% | +20.2% | +43.9% | +10.7% | +20.2% | +7.9% | 0.0% | +11.7% | +6.9% | +21.6% | |
| – | +128.8% | +193.4% | +231.7% | +38.4% | +56.4% | +47.6% | +8.3% | +0.7% | -9.9% | +22.8% | +4.4% | |
| – | +8.3% | -5.2% | -8.1% | +32.7% | +56.2% | +67.1% | +52.5% | +2.4% | +8.2% | -6.0% | +7.1% | |
| – | +40.8% | +50.6% | +15.9% | +24.3% | +19.7% | +22.2% | +17.4% | +5.3% | +23.6% | +15.7% | -6.4% | |
| – | +36.1% | +30.4% | +5.8% | +25.5% | +30.7% | +35.6% | +29.9% | +10.3% | +19.9% | +3.9% | +0.6% | |
| – | – | – | – | – | – | – | -245.8% | – | – | – | – | |
| – | +1,196.7% | +150.2% | +72.8% | +31.5% | +1.7% | +31.6% | -80.9% | -3.1% | +47.2% | +137.7% | +46.1% | |
| – | – | – | – | – | – | – | -387.7% | – | – | – | – | |
| – | +1,060.7% | +134.1% | +26.8% | +33.8% | -109.0% | – | – | +70.3% | +43.2% | +144.8% | -100.1% | |
| – | – | – | – | – | – | – | -394.6% | – | – | – | – | |
| – | – | – | – | – | – | +494.1% | -176.0% | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.